Murine interferon-gamma-inducing factor
Alternative Names: MuIGIFLatest Information Update: 15 Aug 2002
At a glance
- Originator Hayashibara
- Class Antineoplastics
- Mechanism of Action Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Jun 1997 New profile
- 10 Jun 1997 Preclinical development for Cancer in Japan (Unknown route)